MoneyWorks4Me

Biocon informs about company statement

26 Apr 2025 Evaluate
Biocon has enclosed Company Statement with regards to ‘Biocon Biologics Receives Positive CHMP Opinions for Biosimilar Denosumab in Europe’. This information will also be available on the website of the Company at www.biocon.com

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..